Search results for "Risk Reduction Behavior*"

showing 10 items of 58 documents

Effects of exercise and diet interventions on obesity-related sleep disorders in men: study protocol for a randomized controlled trial.

2013

Abstract Background Sleep is essential for normal and healthy living. Lack of good quality sleep affects physical, mental and emotional functions. Currently, the treatments of obesity-related sleep disorders focus more on suppressing sleep-related symptoms pharmaceutically and are often accompanied by side effects. Thus, there is urgent need for alternative ways to combat chronic sleep disorders. This study will investigate underlying mechanisms of the effects of exercise and diet intervention on obesity-related sleep disorders, the role of gut microbiota in relation to poor quality of sleep and day-time sleepiness, as well as the levels of hormones responsible for sleep-wake cycle regulati…

MaleLifestyle interventionTime FactorsPsychological interventionMedicine (miscellaneous)Polysomnographyunettomuuslaw.inventionStudy ProtocolRandomized controlled trialClinical ProtocolslawSleep Initiation and Maintenance DisordersSurveys and QuestionnairesInsomniaMedicinePharmacology (medical)FinlandSleep Apnea Obstructivemedicine.diagnostic_testSleep apneaSleep disordersNeurotransmittersMiddle AgedSleep in non-human animalsExercise TherapyIntestinesTreatment OutcomeResearch Designmedicine.symptomInflammation MediatorsSleep measurementAdultmedicine.medical_specialtyInsomniaPolysomnographyGut microbiotaAerobic exerciseHumansObesityunihäiriötAgedbusiness.industrymedicine.diseaseObstructive sleep apneaHormonesDietQuality of sleepObstructive sleep apneaPhysical therapylihavuusbusinessSleepRisk Reduction BehaviorBiomarkersTrials
researchProduct

Cohort Profile: Design and methods of the PREDIMED-Plus randomized trial

2019

The PREDIMED (in Spanish: PREvención con DIeta MEDiterránea) primary prevention trial1–3 reported in 2013 that long-term adherence to an energy-unrestricted Mediterranean diet (MedDiet), supplemented with either extra-virgin olive oil (EVOO) or nuts, reduced cardiovascular disease (CVD). PREDIMED showed a 30% relative reduction in the composite cardiovascular primary endpoint (stroke, myocardial infarction or cardiovascular death).2,,3 However, the PREDIMED trial tested only the composition of the diet, but did not test other lifestyle interventions (i.e. energy reduction, increased physical activity (PA) and behavioural modification) frequently applied in the context of the current unprece…

MaleResearch designobesitymedicine.medical_specialtyTime FactorsEpidemiologyHealth StatusMEDLINE030204 cardiovascular system & hematologyDiet MediterraneanRisk Assessmentlaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled trialRisk FactorslawSurveys and QuestionnairesmedicineHumansMulticenter Studies as Topic030212 general & internal medicineAgedRandomized Controlled Trials as TopicEvidence-Based Medicinebusiness.industryGeneral MedicineMiddle AgedPredimedDietCardiovascular DiseasesResearch DesignSpainSample size determinationSample SizeCohortPhysical therapyFemalepredimed trialRisk assessmentbusinessRisk Reduction BehaviorInternational Journal of Epidemiology
researchProduct

Protective role of the Mediterranean diet on several cardiovascular risk factors: Evidence from Sicily, southern Italy

2014

Background and aims: Epidemiological studies conducted in European countries demonstrated that the adoption of a Mediterranean diet protect against clustered risk factors but those evaluating such benefits specifically in southern Italy are scarce. Thus, the aim of this study was to assess the association between the adherence to the Mediterranean diet and cardiovascular risk factors obesity, diabetes, and hypertension. Methods and results: A cross-sectional population-based survey including 3090 subjects was conducted in Sicily, southern Italy. Food intake was evaluated through a validated food frequency questionnaire and adherence to the dietary pattern was assessed using the MedDietScore…

MaleSettore MED/09 - Medicina InternaMediterranean dietHealth StatusEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Diet MediterraneanLogistic regressionSettore MED/13 - EndocrinologiaHealth StatuRisk FactorsEnvironmental protectionSurveys and QuestionnairesCardiovascular DiseaseEpidemiologyOdds RatioPrevalenceNutrition and DieteticSurveys and QuestionnaireSettore MED/49 - Scienze Tecniche Dietetiche ApplicateSicilyCardiovascular risk factorsBody mass indexeducation.field_of_studyNutrition and DieteticsMedicine (all)ConfoundingHealth SurveyMiddle AgedCardiovascular DiseasesHypertensionLinear ModelFemaleCardiology and Cardiovascular MedicineHumanAdultmedicine.medical_specialtyLogistic ModelPopulationCardiovascular risk factorMediterranean dietmedicineHumansObesityeducationLife StyleAgedCross-Sectional Studiebusiness.industryRisk FactorOdds ratiomedicine.diseaseHealth SurveysObesityConfidence intervalCross-Sectional StudiesLogistic ModelsLinear ModelsPatient CompliancebusinessRisk Reduction BehaviorDemographyNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies

2019

[Background]: The pandemic of cardiovascular disease (CVD) and type 2 diabetes (T2D) requires the identification of new predictor biomarkers. Biomarkers potentially modifiable with lifestyle changes deserve a special interest. Our aims were to analyze: (a) The associations of lysine, 2-aminoadipic acid (2-AAA) or pipecolic acid with the risk of T2D or CVD in the PREDIMED trial; (b) the effect of the dietary intervention on 1-year changes in these metabolites, and (c) whether the Mediterranean diet (MedDiet) interventions can modify the effects of these metabolites on CVD or T2D risk. [Methods]: Two unstratified case-cohort studies nested within the PREDIMED trial were used. For CVD analyses…

Malelcsh:Diseases of the circulatory (Cardiovascular) systemTime FactorsMediterranean dietEndocrinology Diabetes and MetabolismhumanosDiseaseType 2 diabetes030204 cardiovascular system & hematologyDiet Mediterraneanchemistry.chemical_compound0302 clinical medicineRisk Factorsestudios prospectivosevaluación de riesgosMetabolites030212 general & internal medicineProspective Studiesmediana edadOriginal InvestigationPipecolic acidRandomized Controlled Trials as TopicAged 80 and overancianodietaácidos pipecólicosensayos clínicos controlados aleatorizados como asuntoresultado del tratamientoIncidenceType 2 diabetesMiddle AgedCardiovascular disease3. Good healthPrimary PreventionTreatment OutcomeCardiovascular DiseasesPipecolic AcidsFemaleCardiology and Cardiovascular Medicineconducta de reducción del riesgoCohort studymedicine.medical_specialtyenfermedades cardiovascularesácido 2-aminoadípicoRisk Assessmentincidencia03 medical and health sciencesfactores de tiempoInternal medicineDiabetes mellitusmedicineDiabetes Mellitusfactores de riesgoHumansAngiologyAgedProportional hazards modelbusiness.industryLysinemedicine.diseaseDietlisinaDietary interventionchemistryDiabetes Mellitus Type 2lcsh:RC666-701business2-Aminoadipic AcidRisk Reduction BehaviorBiomarkers
researchProduct

Lipid Profile Results after Cardiovascular Prevention Programme: Euroaction Model in Spain

2020

Background: Cardiovascular prevention and rehabilitation programmes (CVPRP) are an established model of care designed to improve risk factor management. They have been successfully implemented in a variety of settings, in patients with coronary heart disease (CHD). Objective: To assess the long term impact of a nurse-coordinated, multidisciplinary, CVPRP in patients with CHD in the reduction of lipid profile and medication prescription in clinical practice. Methods: The study used an analytical, experimental, population based, prospective and longitudinal design. In Spain, the study was conducted in the Valencian Community, including two randomized hospitals. Coronary patients were prospec…

Malemedicine.medical_specialtyCardiotonic AgentsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentNurse's RoleMedication prescriptionCardiovascular preventionIntervention (counseling)HumansImmunology and AllergyMedicineLongitudinal StudiesProspective StudiesMedical prescriptionHealth policyAgedRehabilitationmedicine.diagnostic_testbusiness.industryMiddle AgedLipidsCoronary heart diseaseEuropePrimary PreventionCardiovascular DiseasesSpainEmergency medicineFemaleDiet HealthyHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessLipid profileRisk Reduction BehaviorEndocrine, Metabolic & Immune Disorders - Drug Targets
researchProduct

EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.

2013

To present a summary of the 2013 version of the European Association of Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms (LUTS). We conducted a literature search in computer databases for relevant articles published between 1966 and 31 October 2012. The Oxford classification system (2001) was used to determine the level of evidence for each article and to assign the grade of recommendation for each treatment modality. Men with mild symptoms are suitable for watchful waiting. All men with bothersome LUTS should be offered lifestyle advice prior to or concurrent with any treatment. Men with bothersome moderate-to-severe LUTS quickly benefit from α1-blocke…

Malemedicine.medical_specialtyPhosphodiesterase Inhibitorsmedicine.medical_treatmentUrologyUrologyProstatic HyperplasiaMuscarinic AntagonistsSeverity of Illness Indexchemistry.chemical_compound5-alpha Reductase InhibitorsLower Urinary Tract SymptomsLower urinary tract symptomsmedicineNocturiaHumansWatchful WaitingTransurethral resection of the prostateUrinary retentionProstatectomybusiness.industryTransurethral Resection of Prostatemedicine.diseaseDutasterideTreatment OutcomechemistryAdrenergic alpha-1 Receptor AntagonistsUrological AgentsProstate surgeryStentsmedicine.symptombusinessUrinary CatheterizationRisk Reduction BehaviorWatchful waitingEuropean urology
researchProduct

Relationship between adherence to the Mediterranean Diet, intracerebral hemorrhage, and its location

2018

INTRODUCTION: Although some authors evaluated the relationship between adherence to the Mediterranean Diet (MeDi) and both ischemic and hemorrhagic stroke, hemorrhagic stroke alone is not yet examined. AIMS: We conducted a retrospective study to evaluate the relationship between adherence to MeDi and intracerebral hemorrhage (ICH) and different locations of ICH (ganglionic/internal capsule, brainstem/cerebellum, or lobar). METHODS: We analyzed charts and collected data of all consecutive patients with ICH admitted to our Internal Medicine Ward from 2005 to 2014. A scale indicating the degree of adherence to the traditional MeDi Score was constructed. RESULTS: When compared with 100 subjects…

Malemedicine.medical_specialtyTime FactorsSettore MED/09 - Medicina InternaInternal capsuleMediterranean dietEndocrinology Diabetes and MetabolismMedicine (miscellaneous)030209 endocrinology & metabolism030204 cardiovascular system & hematologyDiet MediterraneanRisk Assessment03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinePrevalenceHumansMedicineIn patientcardiovascular diseasesStrokeAgedCerebral HemorrhageRetrospective StudiesAged 80 and overIntracerebral hemorrhageNutrition and DieteticsProteinuriabusiness.industryRetrospective cohort studyMiddle AgedProtective FactorsPrognosismedicine.diseaseItalyMediterranean Diet ICHFemaleDiet Healthymedicine.symptomCardiology and Cardiovascular MedicinebusinessRisk Reduction BehaviorDyslipidemiaNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Leisure-time cross-country skiing is associated with lower incidence of hypertension:A prospective cohort study

2019

Abstract Objective: The prospective relationship between cross-country skiing and hypertension is uncertain. We aimed to assess the associations of leisure time cross-country skiing habits with incident hypertension in a general population. Methods: The frequency, average duration, and intensity of leisure cross-country skiing were assessed at baseline using a 12-month physical activity questionnaire in the Kuopio Ischemic Heart Disease prospective study of 1809 middle-aged men without hypertension. Hazard ratios [95% confidence intervals (CIs)] were calculated. Results: New onset diagnosis of hypertension was observed in 279 participants during a median (interquartile range) follow-up of 2…

Malemedicine.medical_specialtyhypertensionPhysiologyPopulation030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineLeisure ActivitiesInterquartile rangeSkiingInternal medicineInternal MedicinemedicineHumans030212 general & internal medicineProspective StudieseducationProspective cohort studyStrokeeducation.field_of_studybusiness.industryPhysical activityIncidence (epidemiology)IncidenceHazard ratioMiddle Agedmedicine.diseasestrokeConfidence intervalHypertensionhigh-intensity exercise trainingCardiology and Cardiovascular MedicinebusinessRisk Reduction Behaviorhuman activitiescross-country skiingCohort study
researchProduct

Hypertension in the metabolic syndrome: Summary of the new position statement of the European Society of Hypertension

2009

Arterial hypertension is often part of a larger constellation of anthropometric and metabolic abnormalities that includes abdominal (or visceral) obesity, characteristic dyslipidemia (low high-density lipoprotein cholesterol and high triglycerides), glucose intolerance, insulin resistance and hyperuricemia. Using Adult Treatment Panel III criteria, prevalence is higher than in the general population and the metabolic syndrome (MS) can be found in as many as one third of patients. In hypertensives with MS, a high prevalence of hypertension-induced target organ damage and a negative prognostic value have been described. Dietary advice and life style changes should be strongly recommended and …

Pediatricsmedicine.medical_specialtyPopulationComorbidityInsulin resistanceInternal MedicinePrevalenceMedicineHumansHyperuricemiaeducationAntihypertensive AgentsSocieties MedicalMetabolic Syndromeeducation.field_of_studybusiness.industrymedicine.diseaseComorbidityObesityEuropeBlood pressureHypertensionPractice Guidelines as TopicMetabolic syndromebusinessRisk Reduction BehaviorDyslipidemia
researchProduct

Sleep apnoea and metabolic dysfunction.

2013

Obstructive sleep apnoea (OSA) is a highly prevalent condition often associated with central obesity. In the past few years, several studies have analysed the potential independent contribution of OSA to the pathogenesis of metabolic abnormalities, including type 2 diabetes, the metabolic syndrome and non-alcoholic fatty liver disease. New perspectives in OSA patient care have been opened by the promotion of lifestyle interventions, such as diet and exercise programmes that could improve both OSA and the metabolic profile. The rich clinical literature on this subject, together with the growing amount of data on pathophysiological mechanisms provided by animal studies using the chronic inter…

Pulmonary and Respiratory Medicinemedicine.medical_specialtymedicine.medical_treatmentReviewDiseaseType 2 diabetesSettore MED/10 - Malattie Dell'Apparato Respiratoriostomatognathic systemRisk FactorsSleep and breathingDiabetes mellitusmedicineAnimalsHumansObesityContinuous positive airway pressureIntensive care medicineLungMetabolic Syndromelcsh:RC705-779Sleep Apnea ObstructiveContinuous Positive Airway Pressurebusiness.industryRespirationSleep apnealcsh:Diseases of the respiratory systemmedicine.diseaseObesitynervous system diseasesrespiratory tract diseasesdiabetes metabolic syndrome weight lossTreatment OutcomeAdipose TissuePhysical therapyMetabolic syndromebusinessRisk Reduction BehaviorSignal Transduction
researchProduct